BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

394 related articles for article (PubMed ID: 27155059)

  • 1. Circulating microRNAs in Huntington's disease: Emerging mediators in metabolic impairment.
    Díez-Planelles C; Sánchez-Lozano P; Crespo MC; Gil-Zamorano J; Ribacoba R; González N; Suárez E; Martínez-Descals A; Martínez-Camblor P; Álvarez V; Martín-Hernández R; Huerta-Ruíz I; González-García I; Cosgaya JM; Visioli F; Dávalos A; Iglesias-Gutiérrez E; Tomás-Zapico C
    Pharmacol Res; 2016 Jun; 108():102-110. PubMed ID: 27155059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. miR-10b-5p expression in Huntington's disease brain relates to age of onset and the extent of striatal involvement.
    Hoss AG; Labadorf A; Latourelle JC; Kartha VK; Hadzi TC; Gusella JF; MacDonald ME; Chen JF; Akbarian S; Weng Z; Vonsattel JP; Myers RH
    BMC Med Genomics; 2015 Mar; 8():10. PubMed ID: 25889241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Customized Dietary Intervention Avoids Unintentional Weight Loss and Modulates Circulating miRNAs Footprint in Huntington's Disease.
    Aganzo M; Montojo MT; López de Las Hazas MC; Martínez-Descals A; Ricote-Vila M; Sanz R; González-Peralta I; Martín-Hernández R; de Dios O; Garcés C; Galdón A; Lorenzo Ó; Tomás-Zapico C; Dávalos A; Vázquez C; González N
    Mol Nutr Food Res; 2018 Dec; 62(23):e1800619. PubMed ID: 30359470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNAs located in the Hox gene clusters are implicated in huntington's disease pathogenesis.
    Hoss AG; Kartha VK; Dong X; Latourelle JC; Dumitriu A; Hadzi TC; Macdonald ME; Gusella JF; Akbarian S; Chen JF; Weng Z; Myers RH
    PLoS Genet; 2014 Feb; 10(2):e1004188. PubMed ID: 24586208
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circulating miR-23b-3p, miR-145-5p and miR-200b-3p are potential biomarkers to monitor acute pain associated with laminitis in horses.
    Lecchi C; Dalla Costa E; Lebelt D; Ferrante V; Canali E; Ceciliani F; Stucke D; Minero M
    Animal; 2018 Feb; 12(2):366-375. PubMed ID: 28689512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of plasma-derived miRNAs mimic differences in Huntington's disease brain.
    Hoss AG; Lagomarsino VN; Frank S; Hadzi TC; Myers RH; Latourelle JC
    Mov Disord; 2015 Dec; 30(14):1961-4. PubMed ID: 26573701
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating microRNAs as biomarkers in progressive multiple sclerosis.
    Vistbakka J; Elovaara I; Lehtimäki T; Hagman S
    Mult Scler; 2017 Mar; 23(3):403-412. PubMed ID: 27246141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of miR-9* in the peripheral leukocytes of Huntington's disease patients.
    Chang KH; Wu YR; Chen CM
    Orphanet J Rare Dis; 2017 Dec; 12(1):185. PubMed ID: 29258536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients.
    Perez-Sanchez C; Font-Ugalde P; Ruiz-Limon P; Lopez-Pedrera C; Castro-Villegas MC; Abalos-Aguilera MC; Barbarroja N; Arias-de la Rosa I; Lopez-Montilla MD; Escudero-Contreras A; Lopez-Medina C; Collantes-Estevez E; Jimenez-Gomez Y
    Hum Mol Genet; 2018 Mar; 27(5):875-890. PubMed ID: 29329380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of circulating microRNAs in patients with repaired Tetralogy of Fallot with and without heart failure.
    Abu-Halima M; Meese E; Keller A; Abdul-Khaliq H; Rädle-Hurst T
    J Transl Med; 2017 Jul; 15(1):156. PubMed ID: 28693530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of circulating microRNA specific for patients with familial adenomatous polyposis.
    Yamano T; Kubo S; Sonoda E; Kominato T; Kimura K; Yasuhara M; Kataoka K; Son J; Babaya A; Takenaka Y; Matsubara T; Beppu N; Ikeda M
    PLoS One; 2021; 16(5):e0250072. PubMed ID: 33945535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Profiling of miRNAs in serum of children with attention-deficit hyperactivity disorder shows significant alterations.
    Zadehbagheri F; Hosseini E; Bagheri-Hosseinabadi Z; Rekabdarkolaee HM; Sadeghi I
    J Psychiatr Res; 2019 Feb; 109():185-192. PubMed ID: 30557705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating microRNAs in patients with immune thrombocytopenia before and after treatment with thrombopoietin-receptor agonists.
    Garabet L; Ghanima W; Rangberg A; Teruel-Montoya R; Martinez C; Lozano ML; Nystrand CF; Bussel JB; Sandset PM; Jonassen CM
    Platelets; 2020; 31(2):198-205. PubMed ID: 30885035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the peripheral blood levels of circulating microRNAs with both recurrent miscarriage and the outcomes of embryo transfer in an in vitro fertilization process.
    Yang Q; Gu WW; Gu Y; Yan NN; Mao YY; Zhen XX; Wang JM; Yang J; Shi HJ; Zhang X; Wang J
    J Transl Med; 2018 Jul; 16(1):186. PubMed ID: 29973278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated Bioinformatics Analysis of Shared Genes, miRNA, Biological Pathways and Their Potential Role as Therapeutic Targets in Huntington's Disease Stages.
    Christodoulou CC; Papanicolaou EZ
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Distinctive expression signatures of serum microRNAs in ischaemic stroke and transient ischaemic attack patients.
    Wu J; Fan CL; Ma LJ; Liu T; Wang C; Song JX; Lv QS; Pan H; Zhang CN; Wang JJ
    Thromb Haemost; 2017 May; 117(5):992-1001. PubMed ID: 28251236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normalizers for microRNA quantification in plasma of patients with vulvar intraepithelial neoplasia lesions and vulvar carcinoma.
    Zalewski K; Misiek M; Kowalik A; Bakuła-Zalewska E; Kopczyński J; Zielińska A; Bidziński M; Radziszewski J; Góźdź S; Kowalewska M
    Tumour Biol; 2017 Nov; 39(11):1010428317717140. PubMed ID: 29299981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioinformatic analysis of a microRNA regulatory network in Huntington's disease.
    Wang ZM; Dong XY; Cong SY
    J Integr Neurosci; 2020 Dec; 19(4):641-650. PubMed ID: 33378838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-34a-5p as molecular hub of pathomechanisms in Huntington's disease.
    Hart M; Diener C; Lunkes L; Rheinheimer S; Krammes L; Keller A; Meese E
    Mol Med; 2023 Apr; 29(1):43. PubMed ID: 37013480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating microRNA-144-3p and miR-762 are novel biomarkers of Graves' disease.
    Yao Q; Wang X; He W; Song Z; Wang B; Zhang J; Qin Q
    Endocrine; 2019 Jul; 65(1):102-109. PubMed ID: 30949910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.